10/9/18 PR, MJNA ANNOUNCES Q3 2018 LARGEST SALES_BOOKINGS_IN_COMPANY_HISTORY!!!
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, Oct. 9, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiary Kannaway® have booked their largest-ever sales revenue quarter in their history in Q3 2018, as well as reached major milestones in their business operations.
Medical Marijuana, Inc. Q3 2018 sales booked exceeded $19 million, an increase of more than 145% over Q3 2017. Kannaway® Q3 2018 sales booked exceeded $16 million, an increase of more than 200% over Q3 2017.
The company experienced many accomplishments in Q3 including its 2018 revenue surpassing its total 2017 revenue in July 2018, signing an agreement with Canadian extraction and formulation company Salvation Botanicals, Ltd. to bring Medical Marijuana, Inc.'s products to Canada, and its subsidiary HempMeds® hiring a new company president.
"In Q3, we are proud to have spread awareness about the benefits of cannabidiol (CBD) and our products through significant media coverage and operational successes," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "As we move into Q4, we will aim to continue expanding the availability of our premium quality products to consumers while also increasing shareholder value."
Medical Marijuana, Inc. and its subsidiaries also garnered positive news coverage in several national and international publications including The Today Show, CBS News, The Wall Street Journal, Reuters, Consumer Reports, Forbes, The Street, Huffington Post, The Spokesman Review, Westword, Direct Selling News, Bustle, Benzinga, Entrepreneur, Mic, and more.
"Our wide range of accomplishments and milestones during Q3 speak to the company's ability to remain a company of firsts within the legal cannabis industry," said Medical Marijuana, Inc. Chief Operating Officer Blake Schroeder. "Our expanding network of Brand Ambassadors make it possible for us to continue to enter new markets and innovate new product offerings."
THIRD QUARTER 2018 HIGHLIGHTS
During the third quarter of 2018, Medical Marijuana, Inc. and its subsidiaries achieved the following milestones and significant events:
HempMeds®
Medical Marijuana, Inc.'s wholly owned subsidiary HempMeds® is the portfolio's predominate consumer brand and saw massive expansion and continued growth for its line of CBD hemp oil products, including the following:
Kannaway®
Medical Marijuana, Inc.'s wholly owned subsidiary Kannaway® is the Company's premier lifestyle marketing brand and is the fastest-growing company in the direct-selling cannabis space with an exponential growth outlook for the future. The company experienced significant milestones including the following:
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
